IRI Trademark

Trademark Overview


On Tuesday, September 3, 2002, a trademark application was filed for IRI with the United States Patent and Trademark Office. The USPTO has given the IRI trademark a serial number of 78160151. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, March 30, 2004. This trademark is owned by LipoScience, Inc.. The IRI trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical laboratory services for others to assess a patient's risk of developing or having diabetes, pre-diabetes, insulin resistance and disorders related to insulin resistance, pre-diabetes, or diabetes, namely, analyzing bio-samples including blood samples, conducting lipoprotein analysis for others, conducting nuclear magnetic resonance spectroscopy based lipoprotein analysis, analyzing various lipoprotein profiles with subclass information, producing customized patient reports thereon, and analyzing a patient's insulin resistance, diabetes, or related disorders or the disease progression, as well as monitoring therapy efficacy based on the results of detailed lipoprotein profiles

Medical services and medical testing services for others to assess a patient`s risk of developing or having diabetes, pre-diabetes, insulin resistance, and insulin resistance, pre-diabetes, or diabetes related disorders

General Information


Serial Number78160151
Word MarkIRI
Filing DateTuesday, September 3, 2002
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, March 30, 2004
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical laboratory services for others to assess a patient's risk of developing or having diabetes, pre-diabetes, insulin resistance and disorders related to insulin resistance, pre-diabetes, or diabetes, namely, analyzing bio-samples including blood samples, conducting lipoprotein analysis for others, conducting nuclear magnetic resonance spectroscopy based lipoprotein analysis, analyzing various lipoprotein profiles with subclass information, producing customized patient reports thereon, and analyzing a patient's insulin resistance, diabetes, or related disorders or the disease progression, as well as monitoring therapy efficacy based on the results of detailed lipoprotein profiles
Goods and ServicesMedical services and medical testing services for others to assess a patient`s risk of developing or having diabetes, pre-diabetes, insulin resistance, and insulin resistance, pre-diabetes, or diabetes related disorders
Pseudo MarkI R I

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateNOT AVAILABLE
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 18, 2002
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLipoScience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27616

Trademark Events


Event DateEvent Description
Tuesday, March 30, 2004ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 31, 2003NON-FINAL ACTION MAILED
Monday, June 30, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 9, 2003CASE FILE IN TICRS
Monday, June 30, 2003TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 11, 2003NON-FINAL ACTION MAILED
Tuesday, January 21, 2003ASSIGNED TO EXAMINER